| Abstrakt: |
Keywords: Farmington; State:Connecticut; United States; North and Central America; Cancer; Carcinomas; Drugs and Therapies; Health and Medicine; Immunotherapy; Melanoma; Oncology; Risk and Prevention; Squamous Cell Carcinoma EN Farmington State:Connecticut United States North and Central America Cancer Carcinomas Drugs and Therapies Health and Medicine Immunotherapy Melanoma Oncology Risk and Prevention Squamous Cell Carcinoma 925 925 1 07/31/23 20230804 NES 230804 2023 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators discuss new findings in Oncology - Squamous Cell Carcinoma. According to the news editors, the research concluded: "Our study revealed that antibiotics-induced abrogation of the microbiome reduced the tumour burden, suggesting a functional role of the microbiome in non-melanoma skin cancer therapy response." Our news editors obtained a quote from the research from Jackson Laboratory for Genomic Medicine, "As squamous cell carcinomas (SCC) are in closest proximity to the skin microbiome, we hypothesized that the skin microbiome, which regulates cutaneous immunity, might affect SCC-associated anti-PD1 immunotherapy treatment response. [Extracted from the article] |
